2026. MOLECULAR GENETIC MARKERS FOR DIAGNOSING METACHRONOUS ONCOGYNECOLOGICAL TUMORS IN BREAST CANCER PATIENTS. Western European Journal of Medicine and Medical Science. 4, 01 (Jan. 2026), 10–18.